Pre-market Hot Trades in US Stocks

General Fusion is up 9.28% in pre-market trading. Based on recent key news:

1. On July 31, General Fusion announced its participation in Canaccord Genuity's 46th Annual Growth Conference. The company will showcase its progress and vision in the field of fusion energy, which has boosted market confidence and driven up the stock price.

2. On July 29, concerns about the lack of new operational catalysts for General Fusion led to a consolidation in the stock price. However, the recent announcement of conference participation has provided the company with a new market focus.

3. On July 31, General Fusion's strategic officials will hold a fireside chat at the conference, further attracting investor attention to the company's strategic direction and future development. The increased focus on the fusion energy industry has intensified market volatility.

Applied Digital is up 7.44% in pre-market trading. Based on recent key news:

1. On July 28, Applied Digital reported its fourth-quarter earnings, with revenue increasing 407% year-over-year to $258.7 million, far exceeding market expectations. Adjusted earnings per share were $0.04, successfully turning a loss into a profit, and the stock price rose nearly 3% in after-hours trading. Data source: Reuters.

2. On July 30, Applied Digital's stock price rose 19.42% as the company's capital expenditure and cloud expansion plans enhanced market expectations for third-party hosting capacity and AI data center demand. Data source: Benzinga.

3. On July 28, analysts maintained a buy rating on Applied Digital with a target price of $83, and the stock price rebounded after the earnings report was released. Data source: Needham and Lucid Capital. AI data center demand is strong, and the industry outlook is optimistic.

Top Gainers in Pre-market US Stocks

WeBus is up 170.67% in pre-market trading. Based on recent key news:

1. On July 30, Wetour Robotics announced a stock consolidation plan with a ratio of 1 to 100. This move aims to enhance the market liquidity and attractiveness of the stock, expected to take effect on August 3. This news may trigger positive expectations for the company's future development, driving up the stock price.

2. On July 29, Fermi and Galaxy Digital faced challenges amid changes in cryptocurrency regulation, leading to fluctuations in investor interest in risk assets. In this context, signals from traditional commodity investment tools are mixed, which may affect market sentiment towards related tech stocks.

3. On July 29, the SEC reminded investors to be cautious about forward-looking statements, emphasizing other factors discussed in the company's SEC filings. Such regulatory information may impact investor confidence in the company's future performance. Tech stocks are significantly affected by changes in cryptocurrency regulation Replimune pre-market up 134.38%. Based on recent key news:

4. On July 31, the FDA external advisory panel supported the trial results of Replimune's RP1 drug, driving the stock price up. The drug is seeking accelerated approval, with a decision expected on August 2. Cantor Fitzgerald believes the FDA will almost certainly follow the advisory panel's recommendation. Source: Reuters

5. On July 28, FDA staff expressed concerns about the efficacy of the RP1 drug, leading to a drop in stock price. Review documents indicated that trial data may have exaggerated the drug's response rate and durability. Source: Reuters

6. On July 30, Replimune announced favorable results from the FDA advisory committee meeting regarding the RP1 drug, causing the stock price to rebound. The company expects a final decision on August 2. Source: Reuters The biotechnology industry faces regulatory challenges, with significant capital inflows.

Mangoceuticals pre-market up 81.71%. Based on recent news,

1. On July 30, Mangoceuticals announced new product news, significantly boosting the stock price. The company released detailed product information via GlobeNewswire, and the market reacted positively, leading to a pre-market increase of 81.71%.

2. On July 30, market expectations for Mangoceuticals' future growth significantly improved. Investors are confident in the market potential of the company's new products, further driving the stock price up.

3. On July 30, analysts upgraded their ratings on Mangoceuticals. Analysts believe the company's new products will significantly enhance its market share, providing positive ratings that promote stock price increases. Market expectations for the new products are driving the stock price up